Compounds > phenytoin
Page last updated: 2024-10-21

phenytoin and Cardiomyopathy, Hypertrophic

phenytoin has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woodcock, BG1
Kirsten, R1
Nelson, K1
Rietbrock, S1
Hopf, R1
Kaltenbach, M1

Other Studies

1 other study available for phenytoin and Cardiomyopathy, Hypertrophic

ArticleYear
A reduction in verapamil concentrations with phenytoin.
    The New England journal of medicine, 1991, Oct-17, Volume: 325, Issue:16

    Topics: Adult; Cardiomyopathy, Hypertrophic; Drug Interactions; Epilepsy; Female; Humans; Phenytoin; Verapam

1991